MediciNova (MNOV)

• Market cap: $66.4M
• 1 day: -2.17%
• 5 days: -4.93%
• 1 month: -8.78%
• 3 months: -11.18%
• 6 months: 8.87%
• Year to date: 1.5%
• 1 year: -8.16%
• 5 years: -79.29%
• 10 years: -77.42%
• Sector: Healthcare
• Industry: Biotechnology

About: MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.

Employees: 6